Great Lakes Breast Cancer Research Symposium 2025

August 24, 2025 to August 26, 2025

Learning Objectives

Apply emerging research findings in breast cancer biology, diagnostics, and therapeutics to inform clinical decision-making and personalize patient care.
Integrate molecular profiling and biomarker data into treatment strategies for various subtypes of breast cancer to enhance treatment precision and outcomes.
Evaluate new and ongoing clinical trials and incorporate trial enrollment into routine patient care where appropriate.
Collaborate effectively across disciplines to develop and implement team-based approaches to breast cancer management.
Identify strategies to address disparities in breast cancer screening, treatment, and follow-up care within diverse patient populations.
Incorporate novel imaging, surgical, and systemic therapy advances into multidisciplinary care plans for patients with early-stage and advanced breast cancer.
Translate basic science discoveries into clinically relevant questions or interventions that can be further studied or implemented in real-world care.

Course summary
Available credit: 
  • 16.50 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 16.50 Attendance
Course opens: 
03/25/2025
Course expires: 
09/30/2025
Event starts: 
08/24/2025 - 1:00pm EDT
Event ends: 
08/26/2025 - 8:00pm EDT
Add to calendar: 
The Assembly
Pittsburgh, PA
United States

Faculty Disclosure:

All individuals in a position to control the content of this education activity have disclosed all financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships for the individuals listed below have been mitigated

Sofia Merajver-Grant/research support with Sofia Geneprex.
Versha Pleasant-Consultant with Pleasant Consulting LLC
Massimo Cristofanilli- Consultant with Pfizer, AstraZeneca, Merck, Data Cancer Genetics, Lilly, Gilead. Grant/research support with AstraZeneca, CelCuity. Speakers Bureau with Pfizer.
Marina Sharifi- Consultant with Artera. Grant/research support with Novartis.
Geoffrey Pecar- Grant/research support with Puma Biotechnology.
Dionisia Quiroga-Consultant with Cardinal Health, LLC.
Julia Foldi-Consultant with Biotheranostics, Inc., A Hologic Company.
Daniel Stover-Consultant with Natera, Guardant. Grant/research support with Foundation Medicine, Inc.
Mihriban Karaayvaz-Received royalties from Curamir Therapeutics.
Li Wang- Received royalties with Immunext Inc, Lebanon, NH.
Marija Balic-Grant/research support with Astra Zeneca, Daiichi Sankyo, Novartis, and Pfizer. Consultant withBMS, Daiichi Sankyo, MSD, Roche, Pierre, Fabre. Speakers/ Bureau with Amgen, AstraZeneca, Daiichi Sankyo, Eli Lilly, Gilead, Menarini, MSD, Novartis Pierre Fabre, Pfizer, Roche, Seagen, Stemline.

No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing  healthcare products used by or on patients. 
 

In support of improving patient care, this activity has been planned and implemented by the University of Pittsburgh, West Virginia University, Ohio State University, Case Western Reserve University, Cleveland Clinic Foundation, University of Michigan, and the University of Wisconsin. The University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician (CME)
The University of Pittsburgh designates this live activity for a maximum of 16.5 AMA PRA Category 1 Credit[s]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Healthcare Professionals: Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Available Credit

  • 16.50 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 16.50 Attendance

Thank you to our exhibitors:


AstraZeneca
Gilead
Hologic
Menarini Stemline
Natera
Pfizer

 

Please login or register to take this course.